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ABSTRACT 
Introduction: Direct peritoneal resuscitation (DPR) has been shown to increase survival 
following intestinal ischemia and reperfusion injury (I/R). We have previously appreciated 
that minimal essential medium (MEM), a synthetic cell culture medium with bovine 
serum, glutamine, and antibiotics, contributes to these benefits. We hypothesized that: 
1) DPR using MEM as a dialysate would increase mesenteric perfusion, improve 
intestinal mucosal injury, and limit intestinal and hepatic inflammation following intestinal 
I/R, and 2) these improvements would be dependent on endothelial nitric oxide 
pathways. 
Methods:  
Eight-week-old C57Bl6J wild type (WT) and eNOS Knock Out (eNOSKO) male mice 
were anesthetized and intestinal ischemia was induced for 60 minutes. Following 
ischemia, 1ml of PBS vehicle or MEM was injected into the abdominal cavity. Intestinal 
perfusion was reassessed after 48h. Animals were then euthanized and intestines and 
livers explanted for histologic and molecular analysis.  
Results:  
DPR with MEM significantly improved mesenteric perfusion compared to vehicle (PBS) 
as measured by Laser Doppler Imaging (WT+MEM 91.58 ± 13.74 % , WT+Vehicle  
44.27 ± 11.93%,  p<0.05), however these benefits were lost when endothelial nitric oxide 
signaling pathways were ablated (eNOS KO+MEM  21.72 ± 5.67 %, eNOSKO+Vehicle  
45.24 ± 11.31%). Wild type mice treated with MEM also had significantly better 
preservation of their mucosal architecture (WT+MEM Mdn=1.0, IQR=1.25 , WT+Vehicle 
Mdn=3.0, IQR=2.0, p<0.05).  When we compared eNOS KO mice treated with either 
MEM or vehicle the protective effect of MEM disappeared (eNOS KO+MEM Mdn=2.0, 
IQR=2.25, eNOS KO+Vehicle Mdn=2.0, IQR=1.0 p>0.05). Intestinal levels of IL-1β were 
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increased in WT animals treated with MEM as compared to eNOSKOs, while 
concentrations of intestinal IL-6 were similar between groups.  Hepatic levels of both IL-
1β and IL-6 were significantly elevated in eNOSKOs compared to WT treated with MEM. 
Conclusion: Direct peritoneal resuscitation with MEM has significant therapeutic 
potential for improving mesenteric perfusion, intestinal injury, and the local inflammatory 
response following intestinal I/R. These benefits appear to be dependent on nitric oxide 
signaling within the endothelium.  
 
KEYWORDS: 
Direct peritoneal resuscitation, ischemia and reperfusion, endothelial nitric oxide 
synthase, Superior Mesenteric Artery, Intestinal Ischemia, perfusion 
 
INTRODUCTION:   
 Acute intestinal ischemia is a highly morbid condition that may result in the need 
for emergent surgical intervention.  The acute inflammatory response associated with 
this condition may lead to multisystem organ failure or death.  Survivors may require life- 
long dependence on total parenteral nutrition, particularly if a large amount of small 
bowel is removed secondary to necrosis [1]. The superior mesenteric artery (SMA) 
supplies blood to most of the small intestine and proximal large intestine [2]. This artery 
is most frequently involved in intestinal vascular events.  Emboli or thromboses within 
this vessel can result in mortality as high as 65% even with treatment [3]. At present 
most therapeutic interventions focus on resolving the acute thrombus and restoring 
blood flow to the ischemic bowel. However, even after restoration of blood flow, 
morbidity and mortality remains quite high [3]. Therefore, alternative strategies that are 
designed to improve intestinal microvascular bloodflow and limit intestinal damage are 
needed.  
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 Previous studies have shown that direct peritoneal resuscitation (DPR) using 
MEM, a synthetic cell culture medium with bovine serum, glutamine, and antibiotics, 
improves survival and decreases inflammation within small intestines in an ischemia and 
reperfusion (I/R) injury model [4]. Peritoneal resuscitation has been utilized for trauma 
and hypothermic resuscitation, has decreased the time to abdominal closure following 
damage control laparotomy, and has reduced intrabdominal complications following 
these trauma related operations[5].   Peritoneal resuscitation has been associated with 
improved hepatic perfusion, decreased organ edema, and lower levels of circulating 
proinflammatory cytokines following abdominal injury [6].  Although the definitive 
molecular mechanisms of DPR therapy have not been elucidated, the protective effects 
may be associated with decreased local or systemic inflammation [7].    
 Although ischemic injury is detrimental to the intestine, the associated reperfusion 
after the thrombus has been removed can provide a “second hit” of injury.  After 
bloodflow is restored, an increase in oxygen to previously ischemic tissue leads to 
formation of reactive oxygen species, which can cause terminal cellular injuries [8].  
Endogenous nitric oxide (NO) is one of the mechanisms by which cells combat reactive 
oxygen species [9].  Increased production of endogenous NO thorough the endothelial 
nitric oxide synthase (eNOS) pathway decreases formation of reactive oxygen species, 
limits the local inflammatory response, and increases vascular dilation [9-11].  
 Direct peritoneal resuscitation may provide a novel therapeutic opportunity for 
clinicians to deliver targeted therapies to ischemic tissues in the early post-ischemic 
state.  We have previously observed a tremendous therapeutic benefit with the use of 
minimal essential cell media (MEM) as a dialysate for DPR following intestinal ischemia.  
It is not known if eNOS pathways play a role in the intestinal recovery following MEM 
infusion.  We therefore hypothesized that: 1) DPR using MEM as a dialysate would 
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increase mesenteric perfusion, improve intestinal mucosal injury, and limit intestinal and 
hepatic inflammation following intestinal I/R, and 2) these improvements would be 
dependent on endothelial nitric oxide pathways. 
 
MATERIALS AND METHODS:  
Murine Model of Intestinal Ischemia and Reperfusion Injury 
 The Indiana University Institutional Animal Care and Use Committee approved the 
experimental protocol and use of animals in this study. Adult male C57BL/6J (Stock No: 
00664) and eNOS KO mice (B6.129P2-Nos3tm1Unc/J, Stock No: 002684) between the 
age of 8 to 12 weeks were purchased from Jackson Laboratory (Bar Harbor, ME) and 
were allowed to acclimate in animal housing for 48 hours prior to experimentation. They 
were allowed free access to standard chow and were kept in a 12 hour light-dark cycle.  
 Animals were divided into 4 groups (WT+Vehicle, WT+MEM, eNOSKO+Vehicle, 
eNOSKO+MEM, N=7/group).  Prior to surgery mice were induced with 3% isoflurane 
and maintained at 1.5% isoflurane in oxygen for the duration of the procedure. A heating 
pad was utilized to achieve homeostatic temperature for the entire duration of 
intervention as well as during the post anesthesia recovery phase. To restore intra- 
operative fluid losses, 1 mL of normal saline was injected subcutaneously prior to start of 
the procedure.  Abdominal hair was removed using hair removal lotion and later prepped 
with 70% alcohol and betadine.  Iodine impregnated dressing (Ioban) was placed on the 
skin of the animal to cover the operative filed prior to incision.  
 A midline laparotomy was performed and the intestines were eviscerated. The 
SMA was identified and a non-traumatic vascular clamp was placed across the root to 
occlude the artery. The intestines were then replaced back into the abdominal cavity and 
skin sutures were placed to prevent evaporative loss of fluid and heat.  After 60 minutes 
of ischemia, the abdominal wall was reopened, the clamp was removed, and direct 
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peritoneal resuscitation was initiated using either 1 mL of Minimum Essential Media 
((Life Technologies) supplemented with 16% fetal bovine serum (Atlanta Biologicals), 
1% penicillin/streptomycin (Sigma-Aldrich), and 1% glutamine (Sigma Aldrich)) in the 
intervention group or 1 mL of Phosphate Buffer Saline (PBS) in the vehicle groups. 
Analgesia was achieved using bupprenorphine (1mg/kg) and carprofen (5mg/kg). After 
completion of surgery animals were placed in a cage without bedding and allowed to 
recover under observation. Once animals were fully recovered they were returned to the 
animal housing facility.  
 
Perfusion analysis: 
 Perfusion was analyzed using a Laser Doppler perfusion Imager (LDI; Moor 
Instruments, Wilmington, DE). Images were acquired at baseline, at the initial clamping 
of the superior mesenteric artery to confirm ischemia, and 48 hours after recovery. A 
region of interest was created around the entirety of exposed intestines to obtain a flux 
mean perfusion within this region.  Three images were acquired at each time point and 
averaged.  Perfusion data was expressed as a percentage of baseline (mean±SEM).  
After the 48 hour recovery analysis, animals were euthanized with isoflurane overdose 
and cervical dislocation, and intestinal tissues were explanted for further analysis.  
Animals that died prior to the 48 hour analysis were given an arbitrary perfusion score of 
0. 
 
Histology Scoring:  
 Intestines were harvested after 48 hours of recovery. Terminal ileal tissue was 
fixed in 4% paraformaldehyde for 24 hours and dehydrated in 70% ethanol. The tissues 
were paraffin-embedded and later stained with hematoxylin and eosin. Histology scoring 
was performed as previously described: 0, no damage; 1, subepithelial space at the 
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villus tips; 2, loss of mucosal lining at the villus tips; 3, loss of less than half of the villus 
structure; 4, loss of more than half of the villus structures; and 5, transmural necrosis 
[12, 13]. All the histology slides were assessed and scored by two blinded authors (SK, 
NAD) and scores were expressed as a median with inter-quartile range 
 
Cytokine Analysis:  
 Following euthanasia, a portion of mouse intestinal and liver tissues were 
harvested, snap frozen, and stored at -80ºC. Tissues were later thawed and 
homogenized in ice cold RIPA buffer (Sigma, St. Louis, MO) with added protease and 
phosphatase inhibitor (1:100 dilution, Sigma, St. Louis, MO) using a Bullet Blender (Next 
Advance, Averill Park, NY). After tissue homogenization, the samples were centrifuged 
at 12,000 rpm to sediment solid particles and the supernatants were transferred to fresh 
Eppendorf tubes.  Protein concentration in each homogenate was quantified using 
Bradford assay with a spectrophotometer (VersaMax microplate reader; Molecular 
Devices, Sunnyvale, CA).  
Intestinal and hepatic IL-1β and IL-6 levels were determined by enzyme-linked 
immunosorbent assay (ELISA) using a commercially available ELISA set (R&D Systems 
Inc., Minneapolis, MN).  ELISA was performed according to the manufacturer’s 
instructions. All samples and standards were measured in duplicate. Values were then 
normalized to total protein concentrations in samples.  MEM treated groups were then 
compared between WT and eNOS KO groups by normalizing treated groups to their 
respective vehicle control.  Data are expressed as folds of vehicle. 
 
Statistical analysis 
Statistical power was calculated using Clinclac number calculator 
(www.clincalc.com) to yield a power of 80% at alpha level of 0.05. We anticipated a 
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mean perfusion of 50 +/- 20 in our wild type and eNOS KO control groups and estimated 
a 50% increase in perfusion in wild type mice treated with MEM. These parameters 
suggested 7 subjects per group.  
Continuous variable such as perfusion and cytokine data were reported as mean 
+/- SEM while ordinal data such as histology scoring was reported as median with inter-
quartile range.  All data were non-parametric and compared using Mann-Whitney test in 
GraphPad Prism 7 (GraphPad Software, La Jolla, CA). A p value of less than 0.05 was 
considered statistically significant.  
 
RESULTS: 
 
DPR with MEM Improves Intestinal Perfusion Following I/R Through eNOS Dependent 
Pathways:  
Intestinal perfusion was measured using Laser Doppler Imaging at 48 hours post 
ischemia.  Two animals died prior to perfusion analysis and one animal had necrotic 
bowel with no flow detected at 48 hours post ischemia.  These animals were given an 
arbitrary perfusion score of 0.  In wild type mice, direct peritoneal resuscitation using 
MEM led to a significantly higher recovery of mesenteric perfusion at 48 hours following 
injury (WT+MEM 91.58 ± 13.74 % , WT+Vehicle  44.27 ± 11.93%,  p<0.05, Figure 1A).  
However, when eNOS was genetically ablated, there was no notable difference in the 
recovery of post-ischemic mesenteric perfusion between MEM or vehicle groups. (eNOS 
KO+MEM  21.72 ± 5.67 % , eNOSKO+Vehicle  45.24 ± 11.31%, Figure 1B).  
 
DPR with MEM Improves Intestinal Mucosal Injury Following I/R Through eNOS 
Dependent Pathways:  
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In wild type mice, direct peritoneal resuscitation using MEM led to significantly 
better preservation of intestinal mucosal architecture compared to PBS vehicle 
(WT+MEM Mdn=1.0, IQR=1.25 , WT+Vehicle Mdn=3.0, IQR=2.0, p<0.05 Figure 2A).  
However, when eNOS was ablated, no notable differences were seen in the post-
ischemic histological architecture of the small intestine in vehicle or MEM treated groups 
(eNOS KO+MEM Mdn=2.0, IQR=2.25, eNOS KO+Vehicle Mdn=2.0, IQR=1.0, Figure 
2B).  
 
Ablation of eNOS Appears to Have a Greater Effect on Hepatic Inflammation Following 
DPR Therapy with MEM 
 Levels of the inflammatory markers IL-1β and IL-6 were assessed as surrogates 
for inflammation within the intestine.  Data are expressed as folds of vehicle.  Following 
DPR therapy with MEM, eNOS ablated animals were found to have lower levels of 
intestinal IL-1β compared to WT.  (eNOSKO 0.73+/-0.10,  WT 2.0+/-0.39, p<0.05, Figure 
3A).  No differences in intestinal IL-6 levels were seen between WT and eNOSKO 
groups with the use of MEM (Figure 3B).  
 Levels of hepatic IL-1β and IL-6 were also assessed.  Following DPR therapy with 
MEM, eNOS ablated animals were found to have higher levels of hepatic IL-1β 
compared to WT.  (eNOSKO 1.4+/-0.19,  WT 0.87+/-0.05, p<0.05, Figure 4A).  eNOS 
ablated animals were also found to have higher levels of hepatic IL-6 compared to WT 
following DPR therapy with MEM.  (eNOSKO 1.4+/-0.21,  WT 0.73+/-0.04, p<0.05, 
Figure 4B). 
 
DISCUSSION:  
 DPR may be used as a novel therapy for those with acute intestinal ischemia. 
Previous studies have shown that DPR improves microcirculatory flow in animal models 
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following injury [14]. The mechanism by which blood flow is more readily restored with 
DPR has not been completely elucidated. Herein we discovered that DPR with MEM 
improves mesenteric perfusion, intestinal injury, and alters intestinal and hepatic 
inflammation following injury.  
 Minimal essential medium (MEM) is a synthetic culture medium with added fetal 
bovine serum (FBS), glutamine, and antibiotics. It is a standard culture media for in vitro 
experiments and is used to maintain homeostasis in a number of different cell lines.  We 
previously hypothesized that this dialysate would also portray protective properties in an 
in vivo model of ischemia.  Based on our previous work, we learned that MEM conveyed 
superior survival benefits compared to either plain (serum free, glutamine free, antibiotic 
free) media or PBS when used as a dialysate during DPR [4]. Previous work also 
showed a correlation between increased survival and improved mesenteric perfusion 
[15, 16].  Therefore, it stood to reason that the survival benefits to MEM would also be 
related to improved perfusion.   
 Endogenous nitric oxide production via the eNOS pathway in endothelial cells is 
essential to combat free radical injury and prevent cellular apoptosis and swelling in I/R 
injury [9]. In addition, these pathways are critical for the process of vasodilation  [17]. 
Therefore, given that we noted improved mesenteric perfusion in treated animals within 
this study, we elected to see if eNOS was important for the observed effects following 
DPR.  We observed a significant increase in the recovery of post-ischemic mesenteric 
perfusion with the addition of MEM when eNOS was present.  However, once it was 
ablated in the knockout animals, DPR with MEM did not appear to offer any further 
protection.  These results would suggest that the use of MEM as a dialysate for DPR, as 
well as the resultant improvements in mesenteric perfusion, work through endothelial 
nitric oxide dependent pathways. 
 In addition, the beneficial effects on mucosal injury also appeared to be mediated 
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by the presence of eNOS.  In eNOS deficient mice, DPR with MEM was not able to 
protect the intestinal mucosa as well as in wildtype animals.  It is difficult in this study to 
determine if DPR had beneficial effects directly on the intestine, or if these results were 
more likely mediated by the presence of better perfusion in wildtype animals.  Given that 
the ablation of eNOS was confined to the endothelium in these knockouts, it is more 
likely that the preservation of histological architecture was due to improvements in post-
ischemic mesenteric perfusion, and a more rapid influx of oxygen and vital nutrients in 
the post-injury phase.   
 The presence of worse hepatic inflammation in eNOSKO animals compared to wild 
type animals was also expected.  There are ample data to suggest that the effects of 
intestinal ischemia not only affect the intestines, but also the liver [15]. Proinflammatory 
cytokines and other inflammatory mediators travel to the liver via portal blood flow 
following intestinal injury.  Therefore, any inflammatory response seen in the intestines is 
likely to be observed in the liver as well.  Herein, we saw that the presence of viable 
eNOS helped to decrease the inflammatory cascade within the liver.  This phenomenon 
was supported by experiments showing less IL-1β and IL-6 in the liver parenchyma 
when eNOS was intact.  When eNOS was ablated, these inflammatory factors 
increased.   
 Although we expected to see higher levels of IL-1β and IL-6 in the intestinal tissue 
with eNOS ablation, we actually saw a decrease in IL-1β and no difference in IL-6 levels 
within the intestine following DPR with MEM.  Although perplexing, it is certainly possible 
that endothelial nitric oxide pathways could actually promote increased IL-1β levels in 
the intestine.  Several studies surrounding endotoxemia and sepsis have shown that IL-
1β promotes NO induced vasodilation [18].  Therefore, in the absence of eNOS, IL-1β 
may be downregulated due to a variety of negative feedback loops.   
 Even though IL-6 was expected to be elevated in these intestines, we did not 
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observe a difference in WT and eNOS treated animals. Death of cells in intestinal tissue 
as a result of severe ischemic injury certainly activates inflammatory cascades, however 
this response has a temporal pattern. Cytokines increase at the onset of insult but as 
time passes they return to normal levels [19]. Our previous experience has shown that 
early tissue harvest and protein quantification leads to significant difference in cytokines 
in intestines of animals that undergone I/R injury [4].  However, we elected to increase 
the recovery time in these experiments to 48 hours in order to capture differences in 
mesenteric perfusion.  In doing this, some of the acute phase reactants, including IL-1β 
and IL-6, may have normalized in certain tissues.  However, this still does not explain 
why these factors continued to be elevated in the liver. 
 In addition to animal experiments, several human trials have demonstrated 
significant benefits with the utilization of DPR. Direct peritoneal resuscitation has been 
proven effective in resuscitation of brain dead cadaver organ donors during the periods 
prior to organ procurement [20].  These donors have impaired hormone physiology, an 
enhanced systemic inflammatory response, and end organ microcirculatory dysfunction.  
Brain dead donors who were treated with DPR had reduced IV fluid requirements and 
vasopressor requirements [20]. DPR has also been used in trauma patients that have 
undergone damage control surgery and has led to decreased time to abdominal closure, 
as well as reduction in intra-abdominal complications following damage control 
emergency surgeries [5]. 
 
  
LIMITATIONS:  
The superior mesenteric artery ligation model of intestinal ischemia and 
reperfusion injury does not model clinical intestinal ischemia to its fullest.  Although 
ischemia of the entire small bowel is possible secondary to SMA thrombus or embolus, 
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the majority of intestinal ischemic episodes are due to segmental ischemia, such as may 
be seen with bowel obstructions or incarcerated hernias.  Nonetheless, this model 
mimics the most severe form of intestinal ischemia, and therefore, is likely the best 
animal model available to test the effectiveness of new therapies.   
 
CONCLUSION:  
 DPR has the potential to revolutionize the management of patients with acute 
intestinal ischemia. Although DPR has proven beneficial in a number of clinical 
scenarios, the choice of the dialysate during therapy is extremely important.  In this 
study, we saw that DPR using minimal essential medium was able to improve post-
ischemic recovery of intestinal blood flow, prevent mucosal injury, and alter the local 
inflammatory response in the intestine and liver.  These beneficial effects appear to be 
mediated, in part, by endothelial nitric oxide pathways.  Clinical trials designed to focus 
on DPR for patients with acute intestinal ischemia should therefore be explored.  
 
 
FIGURE LEGENDS:  
Figure 1: Direct peritoneal resuscitation improves mesenteric perfusion following 
ischemia and reperfusion injury through eNOS dependent pathways. (A) Following 
ischemia-reperfusion injury, Direct Peritoneal Resuscitation using Minimum Essential 
Medium (MEM) improves mesenteric perfusion in wild type mice.  (B) In eNOSKO 
animals, no improvement in mesenteric perfusion was observed following DPR therapy 
with MEM. * = p<0.05 versus WT Vehicle 
 
Figure 2: Histological examination of the small intestine following I/R injury and 
therapy with DPR.  (A) Histological analysis of intestinal tissue shows better 
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preservation of intestinal architecture in wild type animals treated with MEM during DPR. 
(B) eNOSKO animals treated with MEM during DPR did not have any beneficial increase 
in post-ischemic intestinal injury. * = p<0.05 versus WT Vehicle 
 
Figure 3: Intestinal Cytokines following Injury and Treatment with DPR. (A) 
Intestinal concentrations of IL-1β were unexpectedly higher in WT animal intestines as 
compared to eNOSKO.  (B) There were no significant differences in IL-6 levels between 
eNOSKO and WT treated MEM groups. * = p<0.05 versus WT 
 
Figure 4: Hepatic Cytokines following Injury and Treatment with DPR. Hepatic 
concentrations of both (A) IL-1β and (B) IL-6 were significantly elevated following DPR 
with MEM therapy in eNOSKO animals as compared to WT. * = p<0.05 versus WT. 
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